Amarin Corp. Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.38%168.210.7%$1128.84m
PFEPfizer Inc. -0.56%49.580.9%$923.07m
ABBVAbbVie, Inc. -0.50%141.841.9%$815.66m
LLYEli Lilly & Co. 2.73%318.791.1%$806.60m
MRKMerck & Co., Inc. 0.91%91.410.7%$800.09m
BMYBristol-Myers Squibb Co. 0.97%74.851.0%$652.22m
SIGASIGA Technologies, Inc. 2.10%24.830.0%$473.99m
AZNAstraZeneca Plc 0.05%66.771.0%$369.83m
GBTGlobal Blood Therapeutics, Inc. 0.09%67.065.6%$333.03m
GSKGSK Plc -1.48%34.740.3%$280.05m
ALNYAlnylam Pharmaceuticals, Inc. -1.02%225.838.2%$273.71m
VERUVeru, Inc. 9.17%24.290.0%$244.75m
HZNPHorizon Therapeutics Plc -2.53%62.465.4%$214.98m
KRTXKaruna Therapeutics, Inc. 0.76%265.700.0%$206.59m
CCXIChemoCentryx, Inc. 0.14%50.932.9%$202.60m

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.